Lv4
662 积分 2023-09-19 加入
Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
7天前
已完结
Comparative Efficacy of all Available Pharmaceutical Therapies for Moderate to Severe Crohn’s Disease: A Systematic Review and Network Meta-Analysis
7天前
已关闭
Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies
7天前
已完结
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis
7天前
已完结
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches
7天前
已完结
Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions
7天前
已完结
Treat to target in Crohn’s disease: A practical guide for clinicians
7天前
已完结
Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel disease
7天前
已完结
S0897 Efficacy and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases
9天前
已完结
Tofacitinib Is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis
10天前
已完结
皖公网安备34019202002308
